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Abstract
Airway smooth muscle tone is ultimately generated by phosphorylation of myosin
light chain, which is regulated by the balance between concentrations of Ca2+ and
sensitivity to Ca2+ in the cytosolic side. The former is due to the Ca2+ influx passing
through ion channels (Ca2+ dynamics), leading to activation of myosin light chain
kinase, and the latter is due to Rho-kinase (Ca2+ sensitization), leading to the inacti‐
vation of myosin phosphatase. Alterations to contractility and to the proliferative
phenotype, which are influenced by Ca2+ dynamics and Ca2+ sensitization, are in‐
volved in the pathophysiology of asthma and chronic obstructive pulmonary dis‐
ease (COPD). Ca2+ dynamics are mainly due to store-operated capacitative Ca2+
influx and receptor-operated Ca2+ influx, and partly due to L-type voltage-depend‐
ent Ca2+ (VDC) channels. Large-conductance Ca2+-activated K+ (KCa, BKCa, Maxi-K+)
channels are activated by Gs connected to β2-adrenoceptors, whereas these channels
are inhibited by Gi connected to M2 muscarinic receptors. VDC channel activity
regulated by KCa channels contributes to not only functional antagonism between
β2-adrenoceptors and muscarinic receptors but also to synergistic effects between
β2-adrenoceptor agonists and muscarinic receptor antagonists. Moreover, an in‐
crease in Ca2+ influx via the KCa/VDC channel linkage causes airflow limitation and
β2-adrenergic desensitization. In contrast, an increase in sensitivity to Ca2+ via Rho-
kinase causes airflow limitation, airway hyperresponsiveness, β2-adrenergic desen‐
sitization, and airway remodeling. These airway disorders are characteristic
features of asthma and COPD. KCa channels are regulated by trimeric G proteins
(Gs, Gi), and Rho-kinase is regulated by a monomeric G protein (RhoA). Therefore,
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Ca2+ dynamics due to G proteins/KCa/VDC channel linkage and Ca2+ sensitization
due to RhoA/Rho-kinase processes are therapeutic targets for these diseases.
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1. Introduction
Contractility of airway smooth muscle is involved in airflow limitation, which is implicated
in the pathophysiology of asthma and chronic obstructive pulmonary disease (COPD).
Spasmogens act on trimeric G protein-coupled receptors (GPCRs), such as acetylcholine (ACh),
histamine, leukotrienes, and prostaglandins, to mediate airway smooth muscle contraction.
Airway smooth muscle tone is ultimately regulated by the activation of myosin light chain
(MLC); MLC is phosphorylated via myosin light chain kinase (MLCK) and dephosphorylated
via myosin phosphatase (MP). Activation of MLCK contracts airway smooth muscle mediated
by Ca2+-dependent mechanisms, which is due to increased concentrations of intracellular
Ca2+ ([Ca2+]i) via a Ca2+ influx through Ca2+ channels (Ca2+ dynamics). In contrast, inactivation
of MP contracts airway smooth muscle by Ca2+-independent mechanisms, which are due to an
increase in the sensitivity to Ca2+ via Rho-kinase, a protein affected by RhoA, a monomeric G
protein (Ca2+ sensitization) [1]. RhoA/Rho-kinase processes are widely distributed in tissues
including the respiratory system and regulated by agonists for GPCRs.
β2-adreneoceptor agonists and muscarinic receptor antagonists counteract spasmogen-
induced contraction with reducing [Ca2+]i (antagonizing Ca2+ dynamics). β2-adrenoceptor
agonists also suppress airway smooth muscle contraction by reducing sensitivity to Ca2+
(antagonizing Ca2+ sensitization) [1, 2]. Inhibition in both Ca2+ dynamics and Ca2+ sensitization
is involved in the effects of β2-adrenoceptor agonists against spasmogen-induced contraction.
Moreover, β2-adrenoceptor agonists relax airway smooth muscle via 3'-5'-cyclic adenosine
monophosphate (cAMP)-dependent protein kinase (protein kinase A: PKA), leading to
inactivation (phosphorylation) of MLCK. Large-conductance Ca2+-activated K+ (KCa, BKCa,
Maxi-K+) channels are markedly activated by PKA-induced phosphorylation [3, 4, 5, 6] and
Gs-induced action (G, a stimulatory trimeric G protein of adenylyl cyclase) [4, 5, 6, 7]. KCa
channels are activated by β2-adrenoceptor agonists via Gs and suppressed by muscarinic
receptor agonists via Gi, an inhibitory trimeric G protein of adenylyl cyclase [7, 8]. Since KCa
channels have a large conductance of outward currents and exist innumerably on the cell
membrane in airway smooth muscle [9], the opening of these channels also regulates airway
smooth muscle tone mediated by membrane potential-dependent Ca2+ influx (Ca2+ dynamics),
such as L-type voltage-dependent Ca2+ (VDC) channels [10]. Therefore, not only Ca2+ signaling
(Ca2+ dynamics and Ca2+ sensitization) but also KCa channels play a key role in the functional
antagonism between β2-adrenoceptors and muscarinic receptors in airway smooth muscle.
Alterations of contractile phenotype, i.e. hyperresponsiveness to contractile agents (airway
hyperresponsiveness) or hyporesponsiveness to relaxant agents (β2-adrenergic desensitiza‐
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tion), occurs due to intrinsic or extrinsic factors involved in the pathophysiology of asthma.
Dysfunctional contractility, which is a characteristic feature of patients with asthma, may
depend on Ca2+ signaling (Ca2+ dynamics and Ca2+ sensitization) and KCa channels [1, 6, 11,
12]. Furthermore, airway smooth muscle cells have the ability to change the degree of various
functions, such as contractility, proliferation, migration, and synthesis of inflammatory
mediators [1, 13, 14]. The plasticity from a contractile phenotype to other phenotypes (prolif‐
eration, migration, or secretion of chemical mediators) may enhance airway inflammation,
leading to airway remodeling, which is also characterized in asthma. This phenotype change
may also be associated with Ca2+ signaling (Ca2+ dynamics and Ca2+ sensitization) and KCa
channels.
Ca2+ signaling and KCa channels involved in the regulation of airway smooth muscle tone may
be therapeutic targets in asthma and COPD [1, 6, 10, 11, 12, 15]. To elucidate the cause of the
pathophysiology in asthma and COPD, and to establish a rational bronchodilator use for these
diseases, the mechanisms underlying the regulation of airway smooth muscle tone via β2-
adrenergic and muscarinic receptors were examined by using physiological techniques such
as single-channel recording in tracheal smooth muscle cells, isometric tension recordings of
isolated tracheal smooth muscle and simultaneous recording of isometric tension and F340/
F380 in Fura-2–loaded tracheal smooth muscle. In this chapter, the functional characteristics of
airway smooth muscle involved in alterations of contractile and proliferative ability are
focused on Ca2+ signaling (Ca2+ dynamics and Ca2+ sensitization) mediated by G
protein/KCa/VDC linkage and RhoA/Rho-kinase processes.
2. Mechanism of airway smooth muscle tone
Contractile agonists acting on GPCRs cause contraction of airway smooth muscle with
increasing [Ca2+]i mediated by Ca2+ influx passing through Ca2+ channels (Ca2+ dynamics).
When ligands are connected to the GPCRs, receptor-operated Ca2+ (ROC) influx is activated
[16], and Ca2+ is released from sarcoplasmic reticulum (SR) via the production of inositol-1,4,5-
triphosphate (IP3). This Ca2+ release activates store-operated capacitative Ca2+ (SOC) influx
(Figure 1) [17]. Moreover, VDC channels are mainly activated by membrane depolarization
under the condition of high K+ at the extracellular side. Ca2+ influx passing through VDC
channels contributes to high K+-induced contraction. In contrast, VDC is partly involved in the
GPCR-mediated Ca2+ influx [10]. An increase in [Ca2+]i enhances the binding of Ca2+ to
calmodulin (CaM), a calcium-binding messenger protein. MLCK activity is augmented by a
Ca2+-CaM complex (Ca2+/CaM), and MLC is phosphorylated (activated) by MLCK [18], leading
to contraction of airway smooth muscle (Ca2+-dependent contraction: Ca2+ dynamics) [10, 17,
19]. After activated MLC is dephosphorylated (inactivated) by MP, contraction is reversed to
relaxation (Figure 1). On the other hand, contractile agonists activate RhoA mediated by
stimulating GPCRs. RhoA is activated by binding to GTP (RhoA-GTP: active form of RhoA).
Rho-kinase is activated by RhoA-GTP, and MP is phosphorylated by Rho-kinase (MP inacti‐
vation) (Figure 1) [20, 21]. MP is also phosphorylated by CPI-17, which is another potential
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mediator regulated by protein kinase C [22]. Since MLC activity is sustained, not suppressed,
by loss of MLC dephosphorylation via inactivation of MP, airway smooth muscle tone is
enhanced without increasing [Ca2+]i (Ca2+-independent contraction: Ca2+ sensitization) [19, 23].
Airway smooth muscle tone is regulated by the degree of MLC phosphorylation mediated by
both MLCK and MP activity. Alterations of contractile phenotype, which are due to both
Ca2+ dynamics and Ca2+ sensitization, have clinical relevance to airflow limitation, airway
hyperresponsiveness, and reduced responsiveness to β2-adrenoceptor agonists (β2-adrenergic
desensitization), which are implicated with the pathophysiology of obstructive pulmonary






























Figure 1. Role of Ca2+ dynamics and Ca2+ sensitization in the regulation of airway smooth muscle tone. Ca2+ signal‐
ing via Ca2+ dynamics and Ca2+ sensitization contributes to the functional antagonism between β2-adreneceptor ago‐
nists and contractile agonists (such as histamine, ACh, LTs, and PGs), acting on GPCRs. MLC phosphorylation
(pMLC), which is regulated by a balance between MLCK and MP, is fundamental for controlling contraction in airway
smooth muscle. GPCR-related agents cause Ca2+ influx by activating ROC and cause Ca2+ release from SR by producing
IP3. The latter process induces Ca2+ influx via activating SOC. An increase in intracellular concentrations of Ca2+ medi‐
ated by these processes enhances the binding of Ca2+ to CaM. A Ca2+−CaM complex (Ca2+/CaM) augments MLCK activ‐
ity, leading to MLC phosphorylation (Ca2+ dynamics: Ca2+-dependent mechanisms). On the other hand, contractile
agonists activate RhoA by acting on G-protein–coupled receptors. Rho-kinase activated by GTP-RhoA phosphorylates
(inactivates) MP, leading to MLC phosphorylation (Ca2+ sensitization: Ca2+-independent mechanisms). ACh: acetylcho‐
line, LTs: leukotrienes, PGs: prostaglandins, β2: β2-adrenoceptors, GPCRs: G-protein−coupled receptors, AC: adenylyl
cyclase, ROC: receptor-operated Ca2+ influx, SOC: store-operated Ca2+ influx, IP3: inositol-1,4,5-triphosphate, SR: sarco‐
plasmic reticulum, PKA: protein kinase A, CaM: calmodulin, MLCK: myosin light chain kinase, MLC: myosin light
chain, MP: myosin phosphatase, KCa: large-conductance Ca2+-activated K+ channels, VDC: L-type voltage-dependent
Ca2+ channels Illustrated based on ref. [1]
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3. Airway smooth muscle tone regulated by KCa channels
3.1. Characteristics and physiological roles of KCa channels
3.1.1. Structure of KCa channels
KCa channels are composed of a tetramer formed by pore-forming α-subunits along with
accessory β-subunits, and these channels are activated by increased membrane potential and
increased [Ca2+]i. The α-subunit is ubiquitously expressed by mammalian tissues and encoded
by a single gene (Slo, KCNMA1) [24, 25]. The α-subunit transmembrane domains comprise
seven membrane-spanning segments (S0-S6) with extracellular loops and share homology
with all voltage-gated K+ channels with six transmembrane domains (S1-S6) and a pore helix.
S1-S4 are arranged in a bundle that forms the voltage-sensing component, and S5-S6 and pore
helices contribute to form the pore-forming component and the K+ selective filter [26]. The C-
terminal tail confers the Ca2+-sensing ability of the KCa channels, involving a pair of Ca2+-sensing
domains that regulate the conductance of K+ (RCK), i.e., RCK1 and RCK2 [27]. Although the
Ca2+ sensor of the KCa channels has high specificity for Ca2+, other factors including divalent
cations also influence the opening of these channels. Magnesium (Mg2+) enhances activation
of these channels via a distinct binding site in the voltage sensor and RCK1 domain [28]. On
the other hand, intracellular protons (H+) attenuate the opening of the KCa channels [9, 29].
KCa channels associate with modulatory β-subunits, which are expressed in a cell-specific
manner and have unique regulatory actions on these channels. The β-subunits bring about
diversity of the KCa channels. There are four distinct β-subunits, β1-4, which are encoded by
KCNMB1, KCNMB2, KCNMB3, and KCNMB4. These β-subunits in the KCa channels consist
of two transmembrane domains with intracellular N- and C-termini and a long extracellular
loop. The β1 subunit was the first β-subunit to be cloned and is primarily expressed in smooth
muscle [30].
3.1.2. Electrical characteristics of KCa channels
KCa channels are densely distributed on the cell membrane in airway smooth muscle cells and
have a large conductance (about 250 pS in a symmetrical 135-150 mM K+ medium) [31, 32, 33],
as compared to other K+ channels. In freshly isolated human bronchial smooth muscle cells,
single currents of the KCa channels were also recorded in cell-attached patches, inside-out
patches, and outside-out patches [34, 35]. These channels have a conductance of about 210 pS
in symmetrical 140 mM K+ medium. KCa channels are highly selective for K+ despite their large
conductance [36]. Ca2+ sensitivity may be increased by intracellular Mg2+, as is the case in
vascular muscle [37]. Effects of intracellular pH (pHi) on KCa channels have been studied in
rabbit tracheal muscle by using inside-out patches [9]. KCa channel activity was markedly
inhibited by intracellular acidification, by reducing the sensitivity to Ca2+ and also by short‐
ening the open state of the channel. On the other hand, intracellular alkalization had an
opposite effect (increasing Ca2+ sensitivity and lengthening the open state of the channel).
Single-channel currents of KCa channels in guinea pig and canine tracheal muscle, studied in
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outside-out patches, were reversibly blocked by external application of charybdotoxin (ChTX)
or iberiotoxin (IbTX), selective antagonists of KCa channels. This effect was not a result of
reduced current amplitude; rather, it was caused by reducing the open-state probability (nPo),
the fraction of the time during which the channel is open [7, 38]. In bovine trachealis, externally
applied tetraethylammonium (TEA, 1 mM) strongly reduced the amplitude of single KCa
channel current, different from the effects of ChTX (100 nM) on these channels without
affecting current amplitude [32]. The effect of ChTX was also reversible. In contrast, the KCa
channels were not affected by 4-aminopyridine (4-AP, 1 mM) applied internally or (2 mM)
externally.
3.1.3. Physiological role of KCa channels
Typical action potentials have not been found in airway muscle under physiological condi‐
tions. This lack of action potentials is believed to be due to a marked increase in K+ conductance
of the plasma membrane upon depolarization [39]. Thus, when the K+ conductance of the
membrane is reduced by blocking K+ channels, one would expect an increase in excitability.
In airway smooth muscle that is only weakly excitable, spontaneous phasic contractions can
be initiated along with electrical activities by applying K+ channel blocking agents, such as
TEA, 4-AP, ChTX and IbTX [40]. Some of these contractions are accompanied by electrical
activity. These observations suggest that outward K+ currents passing through KCa channels
may be functioning in an important regulatory role in these smooth muscle cells [41].
In excitation-contraction coupling of smooth muscle cells, local increases in Ca2+ concentrations
occur due to focal releases of Ca2+ through ryanodine receptors (RyR) from the sarcoplasmic
reticulum (SR), termed Ca2+ sparks [42]. Hundreds of KCa channels are opened by the Ca2+
sparks from SR close to the sarcolemma, leading to spontaneous outward currents (STOCs)
(Figure 1). The coupling of ryanodine-mediated Ca2+ sparks to KCa channel-mediated STOCs
is enhanced by the β1 subunit, resulting in hyperpolarization of smooth muscle cells and the
subsequent reduction of Ca2+ influx and initiation of muscle relaxation. In KCa channel β1
subunit knockout mice, tracheal contraction induced by carbachol (CCh), a muscarinic
receptor agonist, was enhanced as compared to wild-type mice, and not only the single channel
activity of KCa channels in an inside-out patch but also STOCs in a whole cell configuration
were markedly attenuated in tracheal smooth muscle cells of knockout mice as compared to
wild-type mice [43]. IbTX (30 nM) enhances contraction induced by methacholine (MCh), a
muscarinic receptor agonist, and verapamil, an inhibitor of VDC, suppresses the effect of IbTX
on tension, demonstrating that KCa channel inhibition augments contraction via a Ca2+ influx
through VDC channels [10].
3.2. Stimulatory regulation of KCa channels by β2-adrenergic receptor agonists
3.2.1. cAMP-dependent phosphorylation
The involvement of cAMP-dependent processes in KCa channel regulation has been examined
in rabbit tracheal smooth muscle cells by using single-channel recording. In the presence of
cAMP and adenosine triphosphate (ATP, 0.3 mM), application of PKA (10 units/ml) to the
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cytosolic side of inside-out membrane patches reversibly increased the nPo of KCa channels
without changes in the amplitude of single-channel currents, and the recovery from this
activation was significantly delayed by okadaic acid, an inhibitor of protein phosphatases [3].
A similar effect was observed with the catalytic subunit of PKA (10 units/ml), indicating that
phosphorylation of a KCa channel protein enhances the open state of the channel [3, 4]. External
application of isoprenaline (0.2 μM), a β2-adrenoceptor agonist, and okadaic acid (10 μM) also
increased the activation of KCa channels in the cell-attached patch-clamp configuration, and
the recovery from this activation was also significantly delayed by okadaic acid (Figure 2A)
[3]. In Xenopus oocytes, similar results were observed in β-adrenergic action [44]. Moreover,
external application of forskolin (10 μM), a direct activator of adenylyl cyclase, increased the
KCa channel activity in tracheal smooth muscle cells [45]. These results are in accordance with
results obtained in cultured smooth muscle cells of rat aorta using isoprenaline (10 μM),
forskolin (10 μM), and dibutyryl cAMP (100 μM) in cell-attached patches and by using PKA
(0.5 μM) and cAMP (1 μM) in inside-out patches [46]. These findings demonstrate that β2-




Figure 2. Stimulation and inhibition of KCa channels by β2-adrenoceptor and muscarinic receptor agonists in single-
channel recording of tracheal smooth muscle cells. A: A continuous recording of the effects of external application of
isoprenaline (0.2 μM) and okadaic acid (10 μM) on KCa channels in a cell-attached configuration held at −40 mV. Iso‐
prenaline increased KCa channel activity, and okadaic acid enhanced the effects of isoprenaline on these channels (up‐
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per trace). The time course for washing out the effects of isoprenaline was markedly prolonged in the presence of
okadaic acid (middle trace). These results demonstrate that KCa channel activity is regulated by phosphorylation via
PKA. Okadaic acid augmented KCa channel activity, demonstrating that phosphatase activity is still intact in this exper‐
imental condition (lower trcae). B: A continuous recording of the effects of PKA and αs*GTPγs on KCa channels in an
inside-out patch held at 0 mV (left panel). PKA (0.5 U/ml) maximally increased KCa channel activity, and addition of
the αs*GTPγs (1 nM) enhanced KCa channel activity prestimulated by PKA (0.5 U/ml), indicating that αs activates KCa
channels independent of PKA. Calibration bars, 3 pA and 4 s. Fold stimulation of channel activity are shown under the
condition of addition of PKA (0.5 U/ml) and subsequently by addition of αs*GTPγs (1 nM) (right panel). C: A continu‐
ous recording of the effects of ISO (1 μM) and mACH (10 μM) on KCa channels in an outside-out patch held at 0mV.
External application of ISO increased KCa channel activity, whereas, following washout, mACH decreased this channel
activity (upper trace), indicating that KCa channels are key molecules for the functional antagonisms between these two
receptors. Calibration bars, 3 pA and 10 s. Relationship between nPo and time for an experiment similar to the upper
trace with agonists added in reverse order (lower trace). PKA: protein kinase A, αs: α-subunit of Gs, which is stimulato‐
ry G protein of adenylyl cyclase, ISO: isoprenaline, mACH: methacholine, KCa: large-conductance Ca2+-activated K+
channels, nPo: open−state probability, U: unit. Cited from ref. [3, 4, 7].
3.2.2. Membrane-delimited activation by Gs 30 nM
Activation of KCa channels by isoprenaline is mediated by the α-subunit (αs) of the stimulatory
G protein of adenylyl cyclase (Gs), independent of cAMP-dependent protein phosphorylation
[4, 7]. In porcine, canine and ferret tracheal muscle cells, isoprenaline increased the activation
of KCa channels in outside-out patches when guanosine triphosphate (GTP, 100 μM) was
present at the cytosolic side of the patch. A similar increase in KCa channel activity was also
observed even when phosphorylation was inhibited by the nonmetabolizable ATP analog,
adenosine 5’-[β, γ-imido] diphosphate (ATP [β; γ ΝΗ], AMP-PNP (1 mM)) [4, 7]. In inside-out
patch configuration with a patch pipette containing isoprenaline (1 μM), nonhydrolyzable GTP
analog guanosine 5’-O-(3-thiotriphosphate) (GTP-γ-S, 100 μM) similarly potentiated the KCa
channel activity. The recombinant αs proteins preincubated with GTP-γ-S (αs*GTPγS, 100-1000
pM) increased the channel activity in a concentration-dependent manner when applied to the
cytosolic side of inside-out patches [7]. The maximum effects of αs*GTPγS were observed at
1000 pM, and the nPo of KCa channels was augmented to approximately 16-fold. On the other
hand, αs preincubated with guanosine 5’-O-(2-thio-diphoshate) (GDP-β-S) had no effect on
these channels. These results indicate that the KCa channels are directly activated by αs
(membrane-delimited action) and that cAMP-dependent phosphorylation is not required. A
direct action of Gs protein on the KCa channels has also been demonstrated in channels from
rat or pig myometrium incorporated into planar lipid bilayers, by using GTP-γ-S and AMP-
PNP [47]. β2-adrenoceptor agonists act on smooth muscle without the intracellular signal
transduction processes (the cAMP-PKA pathway).
3.2.3. Dual regulation by cAMP-dependent and -independent processes
To examine whether receptor-channel coupling could occur in β2-adrenergic action on KCa
channels, isoprenaline was applied to outside-out patches in the presence of GTP (100 μM)
and AMP-PNP (1 mM), the competitive ATP inhibitor, in porcine tracheal smooth muscle cells
(Figure 3) [4]. Isoprenaline (1 μM) markedly activated KCa channel activity without an
alteration in current amplitude and returned to the control level within 5 min after drug
washout. The nPo of the channels was increased to approximately fivefold in the presence of
isoprenaline. This result was roughly equivalent to the level of channel stimulation previously
Muscle Cell and Tissue296
reported in outside-out experiments in the absence of ATP, but without AMP-PNP. Consistent
with a membrane-delimited, G protein-dependent coupling mechanism, addition of guanine
nucleotides to the cytosolic side stimulated KCa channel activity in inside-out patches exposed
to isoprenaline on the external side. Internal application of GTP (100 μM) also led to a marked
increase in KCa channel activity; the nPo of the channels was increased to an approximately
equivalent fold, as compared to the experimental condition when isoprenaline was applied to
the outside-out patches in the presence of GTP. Stimulation of channel activity resulted in an
apparent shift in the relationship between voltage and nPo by 10-15 mV after the addition of
100 μM GTP.
cAMP 










Protein kinase A 
relaxation contraction 
Figure 3. Dual pathway and dual regulation of KCa channels in the functional antagonisms between β2-adrenocep‐
tors and muscarinic receptors. At least two mechanisms are involved in activation of KCa channels following the β2-
adrenoceptor activation; one is mediated through cAMP-dependent channel phosphorylation and the other through
direct, cAMP-independent regulation by Gs protein (dual pathway). In contrast, in the muscarinic suppression of KCa
channels, Gi proteins connected to M2 receptors are involved (dual regulation). The relationship between G proteins
and KCa channels, i.e. the Gs/KCa stimulatory linkage and the Gi/KCa inhibitory linkage, may play a key role in the func‐
tional antagonisms (relaxation, contraction) between β2-adrenoceptors and muscarinic receptors in airway smooth
muscle. β2: β2-adrenoceptors, M2: M2 muscarinc receptors, AC: adenylyl cyclase, Gi: inhibitory G protein of adenylyl
cyclase, Gs: stimulatory G protein of adenylyl cyclase, PKA: protein kinase A, KCa: large-conductance Ca2+-activated K+
channels. Illustrated based on ref. [3, 4, 7, 53].
Stimulation of KCa channels by the catalytic subunit of cAMP-dependent PKA was examined
in inside-out patches. KCa channel activity was progressively stimulated by a cumulative dose-
response protocol (PKA between 0.0005 and 5.0 units/ml). The maximum level of KCa channel
stimulation by PKA was observed at either 0.5 or 5.0 units/ml (approximately sevenfold
stimulation). At peak effect, the mean stimulation was approximately 7-fold, which was
substantially less than the approximately 16-fold stimulation previously observed for 1 nM
αs*GTPγS. To examine the dual pathway of β2-adrenoceptor/channel coupling, inside-out
patches were stimulated to near maximum with PKA (0.5 unit/ml). This concentration was
chosen since it provided near maximal stimulation in all patches and a stable stimulation of
channel activity over time. Following incubation with PKA for 5 min, αs*GTPγS (1 nM) was
added. KCa channels were potently activated by the addition of recombinant αs protein after
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stimulation by the near maximally effective concentration of PKA (Figure 2B) [4]. PKA
produced an approximately 6-fold stimulation, and addition of αs produced an approximately
15-fold increase over baseline channel activity (Figure 2B). The fold stimulation produced
during the condition of combined PKA and αs application was more than twice as great as the
maximal fold stimulation that could be produced by PKA alone, suggesting that PKA and αs
affect the channels independently.
The gating kinetics of KCa channels were quantitatively examined by monitoring the effects of
stimulation of channel activity by isoprenaline (outside-out patches) and by PKA and αs
(inside-out patches) at the level of channel open-time kinetics [4]. KCa channel open-times were
well fit by the sum of two exponentials of mean duration τ1 and τ2, similar to previous reports
[8, 9, 48]. The effect of αs on open-time kinetics was remarkably similar to that produced by
isoprenaline on open-time kinetics; that is, αs did not alter the mean lifetimes, but increased
the proportion of long open-time events. In contrast, the major kinetic effect of PKA was on
open-state time constants, resulting in an increase in the mean duration of the long openings.
The effect of PKA on channel kinetics was distinct from that of αs, consistent with distinct or
independent modulatory effects at the channel protein.
3.2.4. Role in relaxation by β2-adrenergic receptor agonists
Airway smooth muscle relaxation produced by β-adrenoceptor activation is generally
accompanied by membrane hyperpolarization, observed with intracellular microelectrodes in
guinea pig, dog, and human tracheal muscles [49, 50], for which activation of KCa channels is
thought to be responsible for the relaxation, as described earlier. This idea is supported by the
observations in guinea pig and human trachealis that the relaxation by noradrenaline (1 μM)
against CCh-induced contraction was nearly blocked by ChTX (50 nM) and that the concen‐
tration-relaxation curves to β2-adrenoceptor agonists, such as isoprenaline and salbutamol,
were selectively shifted to the right by ChTX [51, 52]. The relaxant effect of forskolin on MCh-
induced contraction was also attenuated in the presence of ChTX, similar to isoprenaline [45].
Therefore, an increase in KCa channel activity may contribute to airway smooth muscle
relaxation induced by β2-adrenoceptor agonists and cAMP-related agents. After Gs activity
was irreversibly augmented by incubation with cholera toxin (2 μg/ml) for 6 h in guinea pig
trachea, MCh-induced contraction was significantly attenuated, and this effect by Gs was
reversed in the presence of ChTX (100 nM) [53]. The Gs/KCa stimulatory linkage may also be
involved in β-adrenergic relaxation in airway smooth muscle.
3.3. Inhibitory regulation of KCa channels by muscarinic receptor agonists
3.3.1. Membrane-delimited inhibition by Gi
When MCh (50 μM) was applied to outside-out patches of porcine or canine tracheal muscle
cells, the nPo of the KCa channel was markedly decreased without changes in the amplitude of
single-channel currents [8, 54]. The decreased nPo is due to a reduction in channel open times,
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probably reflecting a decrease in the Ca2+ sensitivity of the channel. The muscarinic inhibition
of KCa channels, similar to that found in airway smooth muscle, has been reported for the
circular muscle of canine colon. The inhibition of KCa channels through muscarinic activation
in guinea pig and swine tracheal muscle cells may be partly responsible for the prolonged
suppression by ACh of STOCs following a transient increase [55, 56]. This suppression has
been observed in longitudinal muscle cells of the rabbit jejunum. As discussed by Saunders
and Farley, this inhibition is difficult to explain by the depletion of intracellular Ca2+ stores,
because it occurs even with elevated Ca2+ concentrations. In the porcine and canine trachealis,
the inhibition of KCa channels produced by muscarinic stimulation was potentiated by cytosolic
application of GTP (100 μM), and strong, irreversible, potentiation was obtained with GTP-γ-
S (100 μM) [8]. On the other hand, when GDP-β-S (1 mM) was applied to the cytosolic side,
muscarinic inhibition was not observed. Incubation (4-6 h) of airway smooth muscle cells with
pertussis toxin (0.1-1.0 μg/ml), which blocks signal transduction through ADP ribosylation of
Gi, the inhibitory G protein of adenylyl cyclase, abolished the channel inhibition by MCh,
without reducing channel activity in the control state [8]. The Gi/KCa inhibitory linkage may
be involved in the muscarinic action in airway smooth muscle.
3.3.2. Dual regulation by Gs and Gi
As described earlier, KCa channels are markedly activated by β2-adrenoceptor agonists; in
contrast, KCa channels are markedly suppressed by muscarinic receptor agonists via G proteins
(Figure 3). The activation process is mediated by the stimulatory G protein, Gs; in contrast, the
suppression process is mediated by the inhibitory G protein, Gi (dual regulation). To demon‐
strate the functional antagonistic, hormone-linked stimulatory and inhibitory regulation of
KCa channels by G proteins at the single-channel level, isoprenaline and MCh were sequentially
applied to identical outside-out patches under the condition of physiologic Ca2+ concentration
and GTP (100 μM) [7]. External application of isoprenaline (1 μM) markedly increased KCa
channel activity, and following drug washout this channel activity reversed to baseline; then,
external application of MCh (10 μM) markedly decreased this channel activity (Figure 2C).
Receptor-linked stimulatory and inhibitory modulation of KCa channels was not sequentially
dependent as shown by an experiment in which this channel activity was inhibited by MCh
and then activated by isoprenaline. Consistent with these outside-out experiments, internal
addition of guanine nucleotides stimulated KCa channels when isoprenaline was present at the
extracellular side in inside-out patches, and conversely, guanine nucleotides suppressed the
channel activity when MCh was present at the extracellular side in inside-out patches [7]. These
results indicate that the functional antagonism between β2-adrenergic and muscarinic action
converges on a single KCa channel current. Therefore, KCa channel activity plays a key role in
the regulation of airway smooth muscle tone.
3.3.3. Role in contraction by muscarinic receptor agonists
After incubation of tracheal smooth muscle with pertussis toxin (1.0 μg/ml for 6 h), MCh-
induced contraction was significantly attenuated, and this effect by pertussis toxin was
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reversed in the presence of ChTX [53]. The Gi/KCa inhibitory linkage may be involved in the
muscarinic-induced contraction in airway smooth muscle. From a functional point of view, it
would be favorable to reduce the K+ conductance of the plasma membrane to produce
excitation by agonists such as ACh. Gi protein couples with the M2 subtype of muscarinic
receptors, leading to an inhibition in cAMP. These M2 receptors exist on the surface of airway
smooth muscle cells. A selective M2 receptor antagonist (AF-DX 116, a benzodiazepine
derivative) suppressed MCh-induced contraction in a concentration-dependent manner and
potentiated relaxation induced by isoprenaline and forskolin in MCh-precontracted tracheal
muscle [53]. AF-DX116 had no effect on isoprenaline-induced relaxation when the preparation
was precontracted with histamine. The functional antagonism between isoprenaline (or
forskolin) and M2 receptor stimulation may not only be simply mediated by inhibition of
adenylyl cyclase through the M2 receptors but also be exerted by the direct inhibition of KCa
channels by pertussis toxin–sensitive Gi protein through activation of muscarinic receptors,
since there is evidence that the activation of KCa channels is involved in the relaxation induced
by forskolin and isoprenaline. Furthermore, M2 receptors inhibited the activity of KCa channels
via dual pathways of a direct membrane-delimited interaction of Gβγ and activation of
phospholipase C/protein kinase C [57]. In KCa channel β1 subunit knockout mice, CCh-induced
contraction and membrane depolarization in tracheal smooth muscle were enhanced as
compared to wild-type mice, and these augmented effects of CCh were inhibited in the
presence of AF-DX116 [43, 58]. These results indicate that the KCa channel β1 subunit plays a
functional role in opposing M2 muscarinic receptor signaling.
3.3.4. Regulation of KCa channels by other factors (cGMP, protein kinase C)
3.3.4.1. NO, cGMP
Nitric oxide (NO), which is primarily generated by nitric oxide synthase (NOS) in the endo‐
thelium, causes relaxation of vascular smooth muscle cells via hyperpolarization of the cell
membrane [59, 60]. NO also augmented the KCa channel activity in vascular smooth muscles,
and NO-induced vasodilation was attenuated by blockade of the KCa channel activity [61]. The
NO/3'-5'-cyclic guanosine monophosphate (cGMP) pathway plays an important role in
relaxation of smooth muscle including vessels and airways. KCa channels were markedly
enhanced by cGMP-mediated processes, suggesting that activation of these channels leads to
cGMP-induced relaxation of smooth muscle [62, 63]. The KCa channel α-subunit null mice had
increased vascular smooth contraction as compared to wild-type mice [64]. This phenomenon
was due to an impaired response to cGMP-dependent vasorelaxation, indicating that the KCa
channel is an important effector for cGMP-mediated action. Protein kinase G (PKG) was
involved in this activation of KCa channels via the NO/cGMP pathway [65, 66]. Activation of
KCa channels via dopamine receptors occurs through PKG and mediates relaxation in coronary
and renal arteries [67]. PKG may be cross-activated by cAMP to stimulate KCa channels [68].
Moreover, dual pathways of KCa channel modulation by NO have been demonstrated; these
pathways are the PKG-dependent pathway [69] and the direct activation of NO with the
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channel protein [70]. Since the stimulatory effect of NO on KCa channels was abolished by
knockdown of the β-subunit with antisense, the β-subunit acts as a mediator of NO [71].
3.3.4.2. Protein kinase C
KCa channels are activated via phosphorylation of their channels by PKA and PKG, as described
earlier. However, the effects of protein kinase C (PKC) on these channels are still controversial.
PKC enhanced the activity of KCa channels in rat pulmonary arterial smooth muscle [72]. In
contrast, PKC reversed cAMP-induced activation of these channels [73]. The phosphorylation
by PKC acts on KCa channels via direct inhibition and also acts as a switch to influence the
effects of PKA and PKG [74, 75]. In addition to these pathways, c-Src and tyrosine kinase
suppressed the activity of the KCa channels in coronary and aortic myocytes [76], whereas cSrc-
induced phosphorylation augmented these channels in HEK 293 cells [77].
3.3.4.3. Redox and ROS
Reactive oxygen species (ROS) synthesized in endothelial and smooth muscle cells exert
physiological and pathophysiological effects on smooth muscle via altering intracellular
reduction and/or oxygen (redox) status [78]. The redox state influences the gating of KCa
channels [79]. However, the effects of redox are complex. Preferential oxidation of methionine
increased the activity of KCa channels, whereas oxidation of cysteines reduced the channel
activity [80, 81]. KCa channel activity was enhanced by hydrogen peroxide (H2O2) in pulmonary
arterial smooth muscle, resulting in vasodilation mediated by membrane hyperpolarization
[82]. Hydrogen peroxide (H2O2) may directly bind to KCa channels to regulate them, or it may
activate these channels via the phospholipase A2-arachidonic acid pathway and metabolites
of lipoxygenase [83]. On the other hand, H2O2 caused contraction of tracheal smooth muscle
in a concentration-dependent fashion and elevation of [Ca2+]i [84]. Moreover, peroxynitrite
(OONO-), an oxidant generated by the reaction of NO and superoxide, caused contraction of
the cerebral artery by inhibiting KCa channel activity [85].
3.3.4.4. Arachidonic acid
Arachidonic acid and its metabolites such as 20-hydroxyeicosatetraenoic acid (20-HETE) and
epoxyeicosatrienoic acids (EETs) play an important role in the regulation of vascular smooth
muscle tone. Arachidonic acid and EETs caused vasodilation mediated by increasing KCa
channel activity [86, 87]. In airway smooth muscle, 20-HETE also caused relaxation with
membrane hyperpolarization via activation of KCa channels [88]. On the other hand, 20-HETE
is a vasoconstrictor. KCa channel activity was inhibited by 20-HETE, and this phenomenon is
mediated by PKC [89]. The vasoconstriction induced by 20-HETE was also attenuated by
increasing KCa channel activity [89]. Acute hypoxia reduced the generation of 20-HETE, and
subsequently the inhibitory action of 20-HETE on KCa channels was removed in cerebral
arterial smooth muscle cells [90].
Ca2+ Dynamics and Ca2+ Sensitization in the Regulation of Airway Smooth Muscle Tone
http://dx.doi.org/10.5772/59347
301
3.4. Synergistic effects between muscarinic and β2-adrenergic receptors
The combination of muscarinic receptor antagonists with β2-adrenoceptor agonists has
pharmacological rationale as a bronchodilator therapy for COPD [91]. In the human airway,
muscarinic contraction is more resistant to β2-adrenoceptor–induced relaxation than that
induced by other contractile agonists [92]. Muscarinic receptors and β2-adrenoceptors are
unevenly distributed in the human airways. β2-adrenoceptors were increased in the distal
airways: segmental bronchus < subsegmental bronchus < lung parenchyma [93]. M3 receptors
are expressed more exclusively in segmental than subsegmental bronchus; in contrast, the
M2 subtype is widely distributed throughout the airways, while the M1 subtype is found only
in parenchyma [93]. These findings may explain why combined inhalation of a muscarinic
antagonist and a β2-adreneceptor agonist causes greater bronchodilation than monotherapy
[94]. Furthermore, characteristic interactions between muscarinic receptors and β2-adreno‐
ceptors are involved in prejunctional modulation of ACh release from parasympathetic nerve
endings [95] and intracellular signaling cross-talk at the adenylyl cyclase/PKA level [96],
resulting in synergistic effects on relaxation of airway smooth muscle. KCa channel activity may
contribute to these interactions between these two receptors; however, little is known about
the detailed underlying mechanisms.
In isometric tension recordings of guinea pig tracheal smooth muscle, indacaterol (1 nM), a
long-acting β2-adrenoceptor agonist, modestly inhibited MCh-induced contraction (1 μM)
(Figure 4A). When glycopyrronium bromide (10 nM), a long-acting muscarinic receptor
antagonist, was applied in the presence of indacaterol (1 nM), the relaxant effect of glycopyr‐
ronium bromide was significantly augmented (Figure 4A) [97]. The value of percent relaxation
for the combination of indacaterol with glycopyrronium bromide was more than the sum of
that for each agent. Similar results were observed between indacaterol (1 nM) and glycopyr‐
ronium (3-30 nM) [97]. Moreover, similar results were also observed between other β2-
adreneceptor agonists, such as salbutamol and procaterol, and other muscarinic receptor
antagonists, such as atropine and tiotropium (our unpublished observation). These results
indicate that the combination of muscarinic receptor antagonists with β2-adrenoceptor
agonists causes a synergistic inhibition against muscarinic contraction. This phenomenon was
observed in isolated human bronchus [98]. This synergistic effect was enhanced after exposure
to pertussis toxin (1 μg/ml) or cholera toxin (2 μg/ml) for 6 h; in contrast, the effect was
attenuated in the presence ChTX (100 nM) or IbTX (30 nM). A reduction in this synergistic
effect induced by ChTX or IbTX was reversed to the control response in the presence of
verapamil (Figure 4B) [99]. Inactivation of the Gi/KCa inhibitory linkage and activation of the
Gs/KCa stimulatory linkage are involved in this synergistic effect between muscarinic receptor
antagonists and β2-adrenoceptor agonists in airway smooth muscle (Figure 3) [4, 7, 53].
Moreover, the KCa/VDC channel linkage is also involved in this synergistic effect. On the other
hand, synergistic effects did not occur between β2-adrenoceptor agonists and theophylline in
airway smooth muscle (our unpublished observation). Although the clinical relevance of this
result is still unknown, this result may provide evidence that combination therapy between
muscarinic receptor antagonists and β2-adrenoceptor agonists is an effective bronchodilator
therapy for COPD [100].





































Figure 4. Synergistic action in combination of β2-adrenocetor agonists with muscarinic receptor antagonists against
tracheal smooth muscle contraction. A: Left panel: A typical example of the inhibitory effects of GB (10 nM), a long-
acting muscarinic receptor antagonist (LAMA) against MCh (1 μM)-induced contraction (upper trace). A typical exam‐
ple of the inhibitory effects of equimolar amounts of GB in the presence of indacaterol (1 nM), a long-acting β2-
adrenoceptor agonist (LABA) against MCh-induced contraction (1 μM) (lower trace). Right panel: Percent inhibition of
combining GB with indacaterol is greater than the sum of each agent, demonstrating synergistic action between β2-
adrenoceptor agonists and muscarinic receptor antagonists. B: The percent inhibition of GB (10 nM) with indacaterol (1
nM) against MCh-induced contraction (1 μM) was markedly augmented after incubation with PTX (1 μg/ml) and CTX
(2 μg/ml) for 6 h. In contrast, the percent inhibition was significantly attenuated in the presence of ChTX (100 nM), and
this ChTX-induced effect was reversed to the control level by addition of Vera (1 μM). These results indicate that the G
proteins (Gi, Gs)/KCa channel linkage and the KCa/VDC channel linkage contributed to this synergistic action, similar to
the mechanisms shown in Figures 1, 3. GB: glycopyrronium bromide, MCh: methacholine, PTX: pertussis toxin, CTX:
cholera toxin, ChTX: charybdotoxin, Vera: verapamil, KCa: large-conductance Ca2+-activated K+ channels, VDC: L-type
voltage-dependent Ca2+ channels. Cited from ref. [97, 99].
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4. Airway smooth muscle tone regulated by Ca2+ dynamics
4.1. Membrane potential-independent Ca2+ dynamics
In simultaneous recordings of isometric tension and [Ca2+]i in fura-2-loaded tissues of tracheal
smooth muscle, various spasmogens including contractile agonists acting on GPCRs augment
the tone of airway smooth muscle with elevated [Ca2+]i in a concentration-dependent fashion
(Figure 1) [19, 101]. However, even though contraction fully occurs, these agents cause a
modest depolarization of the cell membrane in a microelectrode experiment, indicating that
airway smooth muscle contracts by Ca2+ influx via membrane potential–independent path‐
ways. These Ca2+ dynamics with a modest depolarization are involved in Ca2+ influx through
SOC and ROC [16, 17]. Depletion of the SR Ca2+ stores by thapsigargin, an inhibitor of the SR
Ca2+-ATPase, caused an increase in [Ca2+]i and contraction, demonstrating Ca2+ entry through
SOC [17]. Because SOC was not inhibited by nifedipine, an inhibitor of VDC, VDC is not
involved in SOC. Under the condition that SOC is fully activated, MCh and histamine caused
further increases in [Ca2+]i and tension, demonstrating Ca2+ entry independent of SOC and VDC
(non-SOC) [17]. The Ca2+ influx and contraction via non-SOC was inhibited by Y-27632. In
contrast, Y-27632 did not affect SOC.
4.2. Membrane potential–dependent Ca2+ dynamics
In fura-2–loaded tissues of tracheal smooth muscle, verapamil caused an inhibition of MCh-
induced contraction with reduced [Ca2+]I; however, relaxant effects of verapamil are not so
dramatic, indicating that VDC is partly involved in contraction mediated by GPCRs. IbTX
enhanced MCh-induced contraction with elevation of [Ca2+]i. These effects of IbTX on tension
and [Ca2+]i are antagonized by verapamil [10], demonstrating that KCa channel inhibition results
in contraction with elevation of [Ca2+]i induced by opening VDC channels via depolarization
of the cell membrane, whereas channel activation results in relaxation with reduction of
[Ca2+]i induced by closing VDC channels via hyperpolarization of cell membrane.
When [Ca2+]i is increased by Ca2+ entry via various pathways described earlier (Ca2+ dynamics),
the activity of MLCK is enhanced via CaM, leading to contraction via phosphorylation of MLC
(see Section 2). In airway smooth muscle, alteration of contractility regulated by Ca2+ dynamics
is involved in the pathophysiology implicated in asthma and COPD, such as airway limitation,
airway hyperresponsiveness, and β2-adrenergic desensitization. It is useful to suppress Ca2+
dynamics for improving these pathological conditions in the airways.
4.3. Effects of Ca2+ release from the SR
KCa channels were activated by ACh (30 μM), substance P (0.1 μM) or IP3 (2.4-20 μM), as well
as by caffeine (5 mM), suggesting that the activity was due to Ca2+ released from intracellular
stores. These activations with the agonists and IP3 were markedly and reversibly reduced by
heparin (50-100 μg/ml), which inhibits IP3 binding to its receptors in the SR. Furthermore, in
cultured human bronchial smooth bradykinin (0.01-1 μM), an inflammatory mediator caused
bronchoconstriction and activated KCa channels in a concentration-dependent manner; the
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augmented currents were inhibited by heparin (10 μg/ml) [102]. Ca2+ release from the SR via
stimulation of IP3 receptors causes an increase in the activation of KCa channels in smooth
muscle including airways and vessels. Two pathways participate in Ca2+ release from the SR,
the RyR pathway and the IP3 receptor pathway. In smooth muscle cells, the IP3 receptor is more
abundant than the ryanodine receptor and reacts to IP3, which is generated from the activation
of GPCRs and phospholipase C.
5. Airway smooth muscle tone regulated by Ca2+ sensitization
5.1. Characteristics and physiological role of RhoA/Rho-kinase
Although an increase in [Ca2+]i plays an important role in the contraction of airway smooth
muscle (Figure 1) [18], it is generally considered that muscarinic receptor agonists and
histamine increase tension at a constant [Ca2+]i. This phenomenon is referred to as Ca2+
sensitization [103, 104] and is mediated by a G protein-coupled mechanism. Rho is a mono‐
meric G protein that belongs to the Ras superfamily. The Rho family makes up a major branch
that contains Rho, Rac, and CdC42. Rho has isoforms of A-G; however, most of the function
is described based on studies of RhoA. RhoA exhibits both GDP/GTP binding activity and
GTPase activity, and it acts as a molecular switch between a GDP-bound inactive state (GDP-
RhoA) and a GTP-bound active state (GTP-RhoA). When cells are stimulated with G protein–
coupled receptor agonists, receptor tyrosine kinases and higher concentrations of potassium
chloride (KCl), GDP-RhoA is converted to GTP-RhoA. RhoA and Rho-kinase are widely
distributed to many organs, including the respiratory system. Rho-kinase (160 kDa) is an
effector molecule of RhoA [105, 106]. Rho-kinase activated by GTP-RhoA interacts with MP
and hinders MP activity by phosphorylating threonine 696 and 853 of myosin phosphatase
targeting subunit 1 (MYPT1), a myosin-binding subunit [107, 108]. Rho-kinase has effects on
contraction due to Ca2+ sensitization, stress fiber formation due to actin (cytoskeletal) reor‐
ganization, cell migration, and cell proliferation [20, 109]. These processes are implicated in
the major pathophysiological characteristics of asthma and COPD, such as airflow limitation,
airway hyperresponsiveness, β2-adrenergic desensitization, eosinophil recruitment and
airway remodeling [1].
5.2. Role of RhoA/Rho-kinase on contraction
Y-27632, a pyridine derivative, was developed as a specific Rho-kinase inhibitor. Y-27632
suppresses Ca2+ sensitization and relaxes vascular smooth muscle to treat hypertension in rats
[21]. The effects of Y-27632 on MCh-induced contraction were analyzed by using strips of
guinea pig airway smooth muscle treated with fura-2. Y-227632 suppressed contraction
induced by agonists, such as MCh, histamine, prostaglandins, and leukotrienes, in a concen‐
tration-dependent manner, but there was no significant decrease in [Ca2+]i [19]. Recently, it has
been demonstrated that MYPT1 is an effective protein for Rho-kinase action on MP in airway
smooth muscle cells and that Y-27632 inhibits the phosphorylation of MYPT1 in a concentra‐
tion-dependent manner [108, 110]. Fasudil hydrochloride (HA-1077), a specific inhibitor of
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Rho-kinase, is used clinically to suppress cerebral vasospasm following subarachnoid
hemorrhage [111]. Alteration of contractility of airway smooth muscle regulated by Ca2+
sensitization is also involved in airflow limitation, airway hyperresponsiveness, and β2-
adrenegic desensitization [1].
6. Role of Ca2+ dynamics and Ca2+ sensitization in airway disorders
6.1. Airflow limitation (contraction)
Airway smooth muscle contraction due to muscarinic receptor agonists (ACh, MCh and CCh),
histamine, prostaglandins or leukotrienes is involved in airflow limitation, which is a charac‐
teristic feature of asthma and COPD (Figure 5). These agonists cause contraction of airway
smooth muscle with increasing [Ca2+]i by Ca2+ dynamics via Ca2+ entry passing through SOC,
ROC, and partly VDC. Sphingosine 1-phosphate (S1P: a bioactive lysophospholipid) [108],
tryptase (trypsin-like neutral serine-class protease) and SLIGKV (non-enzymatic activator of
protease-activated receptor 2, PAR2) [112] released from mast cells induce airway smooth
muscle contraction with increasing [Ca2+]i. Since clinical studies have demonstrated that S1P
and tryptase may be involved in the pathophysiology of asthma, these substances have been
examined as novel mediators. ATP is released from injured airway epithelium during the
inflammatory processes implicated in asthma. Extracellular ATP also causes contraction of
airway smooth muscle with increasing [Ca2+]i [113]. Furthermore, oxidative stress and
mechanical stress are related to the pathophysiology of not only COPD but also asthma. 8-iso-
prostaglandin F2α, an isoprostane [114], and hydrogen peroxide (H2O2) [84] produced by
oxidative stress contract airway smooth muscle by increasing [Ca2+]i.
As described earlier, Y-27632 inhibited the contraction induced by spasmogens such as MCh,
histamine, prostaglandins, and leukotrienes, which are involved in the pathophysiology of
asthma and COPD, in a concentration-dependent manner, with no significant decrease in
[Ca2+]i in strips of guinea pig airway smooth muscle treated with fura-2. Furthermore, Y-27632
also inhibited the following types of contraction in a concentration-dependent manner with a
modest effect on [Ca2+]i: contraction due to S1P and tryptase released from mast cells; contrac‐
tion due to isoprostanes and Hydrogen peroxide (H2O2) produced by oxidative stress; and
contraction due to ATP synthesized in injured airway epithelium. Spasmogens, which are
implicated in the pathophysiology of asthma and COPD, cause force generation in airway
smooth muscle via both Ca2+ influx and Ca2+ sensitization [115]. Force maintenance is due to
Ca2+ sensitization induced by Rho-kinase [116]. PKC, which is an intracellular signal trans‐
duction pathway for GPCR activation, also contracts airway smooth muscle mediated by both
Ca2+ dynamics and Ca2+ sensitization [22].
These findings indicate that a contractile phenotype in airway smooth muscle cells is altered
by the inflammatory processes related to obstructive pulmonary diseases, such as asthma and
COPD, via both Ca2+ dynamics and Ca2+ sensitization, leading to the airflow limitation
(bronchoconstriction) associated with these diseases (Figure 5).
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6.2. Airway hyperresponsiveness
Airway hyperresponsiveness is a characteristic feature of asthma, and it is essential for the
diagnosis and severity assessment of asthma. Airway hyperresponsiveness is also observed
in some patients with COPD. This airway disorder is clinically defined as increased respon‐
siveness to muscarinic receptor agonists (ACh and MCh) and histamine. Airway hyperres‐
ponsiveness is mediated by various inflammatory stimulations involved in the
pathophysiology of asthma, such as antigens, chemical mediators, cytokines, and eicosanoids.
In a postmortem study of airway smooth muscle strips of patients with asthma, the response
to histamine and ACh was greater than in healthy individuals [117]. In human airway smooth
muscle passively sensitized with human asthmatic serum, contraction due to histamine is
significantly elevated [118]. When airway smooth muscle is exposed for an extended period
of time to interleukin (IL)-5, IL-13, IL-17, or tumor necrosis factor (TNF)α, which are released
from inflammatory cells and epithelial cells in airways, contraction due to muscarinic receptor
agonists and KCl is significantly increased [119, 120, 121]. This enhancement of contraction
induced by TNFα may be involved in Ca2+ sensitization via RhoA/Rho-kinase [110]. In the





















Figure 5. Involvement of G proteins/KCa/VDC channel linkage (Ca2+ dynamics) and RhoA/Rho-kinase processes
(Ca2+ sensitization) in the pathophysiology of asthma and COPD. Chronic exposure to lipid mediators, cytokines,
and other substances related to asthma and COPD, which are released and synthesized from inflammatory cells and
epithelial cells in airways, affects airway smooth muscle functions via the G proteins/KCa/VDC channel linkage due to
Ca2+ dynamics and RhoA/Rho-kinase processes due to Ca2+ sensitization. These inflammatory processes cause not only
alterations of contractility but also changing to proliferative phonotype in airway smooth muscle, referred to as a phe‐
notype change. The former phenomenon is attributed to airflow limitation, airway hyperresponsiveness, and β2-adre‐
nergic desensitization; the latter phenomenon is attributed to airway remodeling via cell proliferation and migration.
Therefore, G proteins/KCa/VDC channel linkage and RhoA/Rho-kinase processes are involved in almost all of the prin‐
cipal mechanisms of asthma and COPD. These pathways involved in Ca2+ dynamics and Ca2+ sensitization are molecu‐
lar targets for therapy of these diseases. VDC: L-type voltage-dependent Ca2+ channels, KCa: large-conductance Ca2+-
activated K+ channels. Illustrated based on ref. [1].
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augmented in porcine tracheal smooth muscle, and this enhanced contraction due to KCl is
attenuated by Y-27632 [122]. When airway smooth muscle is exposed to S1P released from
mast cells or ATP released from damaged epithelial cells, contraction in response to MCh is
markedly increased after exposure to S1P or ATP, and its augmented contraction is suppressed
by Y-27632 in a concentration-dependent manner [108, 113, 123]. Furthermore, pre-treatment
of 8-iso-prostaglandin E2, an isoprostane, causes an increased response to CCh in airway
smooth muscle, and its augmented contraction is suppressed by Y-27632 [124]. These obser‐
vations indicate that airway hyperresponsiveness is caused by direct interactions among
inflammatory cells, airway epithelial cells and airway smooth muscle cells and that Ca2+
sensitization based on Rho-kinase–induced MYPT1 phosphorylation contributes to the airway
hyperreactivity [107, 108]. Suppression of geranylgeranyltransferase, which is involved in the
activation of RhoA, also reduces hyperresponsiveness in mouse bronchus [125]. Alterations of
Ca2+ regulatory mechanisms in airway smooth muscle may play a key role in this phenomenon.
Therefore, the pathophysiology of asthma (inflammatory processes involved in this disease)
and alterations in the mechanical properties directly affect the function of airway smooth
muscle cells via the RhoA/Rho-kinase processes. In airway smooth muscle cells, this pheno‐
typic change for contractility induced by not only Ca2+ sensitization but also cytoskeleton
reorganization (cell stiffness) may cause an augmented response to spasmogens [1, 126, 127].
Lung resistance in response to MCh was increased in mice sensitized by allergen challenges,
as compared with control mice (airway hyperresponsiveness). Fasudil hydrochloride
(HA-1077), an inhibitor of Rho-kinase, suppressed the augmented response to MCh by allergen
challenges [128]. On the other hand, Ca2+ dynamics (Ca2+ mobilization) also contributes to
altering the contractile phenotype of airway smooth muscle, leading to augmented respon‐
siveness to spasmogens [129]. Moreover, acidification of esophageal lumen increases the
contractile response to ACh and KCl in guinea pig trachealis mediated by activation of VDC
channels and Rho-kinase [130], indicating that both Ca2+ dynamics and Ca2+ sensitization play
key roles in airway hyperresponsiveness (Figure 5).
6.3. Desensitization of β2-adrenergic receptors
After β2-adrenoceptors are excessively activated, responsiveness to an agonist is attenuated.
This phenomenon is referred to as desensitization of β2-adrenoceptors. The phosphorylation
of β2-adrenoceptors, which leads to desensitization via uncoupling Gs from the receptors, is
mediated by two types of protein kinases, cAMP-dependent PKA and cAMP-independent
protein kinases such as β2-adrenergic receptor kinase (βARK) [131]. PKA-induced phosphor‐
ylation, which is produced by exposure to a low concentration of β2-adrenoceptor agonists,
leads to heterologous desensitization (a nonspecific reduced response to other agonists
involving cAMP) [132]. On the other hand, βARK-induced phosphorylation, which is pro‐
duced by exposure to a high concentration of β2-adrenoceptor agonists, leads to homologous
desensitization (a specific reduced response to β2-adrenoceptor agonist) [133]. These phenom‐
ena also occur in tracheal smooth muscle, including human tissues [10, 134, 135, 136]. β2-
adrenergic desensitization occurs after continuous [134, 135, 136] or repetitive administration
[10, 135, 136] of β2-adrenoceptor agonists or after exposure to substances related to the
inflammatory processes in asthma, including inflammatory cytokines such as IL-1β [137],
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growth factors such as transforming growth factor (TGF)-β1 [138] and platelet-derived growth
factor (PDGF) [139], lipid mediators such as lysophosphatidylcholine (Lyso-PC), a lysophos‐
pholipid produced by phospholipase A2 [140], and S1P [141], or PAR2 agonists such as tryptase
and SLIGKV [112]. Therefore, desensitization of β2-adrenoceptors in airway smooth muscle is
an extremely important phenomenon that occurs due to both the treatment and the patho‐
physiology of asthma. Reduced responsiveness to β2-adrenoceptor agonists after excessive or
repeated exposure to these agonists was prevented when Gs linked to β2-adrenoceptors was
irreversibly activated by pre-treating airway smooth muscle with cholera toxin (2 μg/ml) for
6 h [134, 135, 142, 143] (Figure 6A). On the other hand, in the presence of ChTX or IbTX, this
β2-adrenergic desensitization was markedly enhanced [134, 135]. Inactivation of the Gs/KCa
channel linkage plays an important role in β2-adrenergic desensitization (Figures 5, 8).
(A) (B) 
(C) 
Fig  6 Figure 6. Inhibitory effects of Gs/KCa channel linkage on the β-adrenergic desensitization after repeated exposure to
a β-adrenoceptor agonist in isometric tension recording of tracheal smooth muscle. (A) A typical example of repeat‐
ed application of ISO (0.3 μM) to tissues precontracted by MCh (1 μM) at intervals of 20 min under the following ex‐
perimental conditions: control (upper trace), preincubation with CTX (2 μg/ml) for 6 h (middle trace), and
preincubation with CTX and in the presence of IbTX (30 nM) throughout the experiment (lower trace). The Gs/KCa
channel stimulatory linkage is involved in the prevention of β2-adrenergic desensitization. (B) A typical example of
simultaneously recorded isometric tension (upper trace) and F340/F380 (lower trace) after repeated exposure to MCh (1
μM) with ISO (0.3 μM) in fura-2–loaded tissues of tracheal smooth muscle in guinea pigs. (C) A typical example of
simultaneously recorded isometric tension (upper trace) and F340/F380 (lower trace) after repeated exposure to MCh (1
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μΜ) with ISO (0.3 μM) in the presence of verapamil (3 μM) in fura-2–loaded tissues similar to (B). Ca2+ dynamics via
the KCa/VDC channel linkage are involved in β2-adrenergic desensitization. ISO: isoprenaline, MCh: methacholine,
CTX: cholera toxin, IbTX: iberiotoxin, KCa channels: large-conductance Ca2+-activated K+ channels. Cited from ref. [10,
135].
6.3.1. Ca2+ dynamics
In fura-2–loaded tissues of guinea pig tracheal smooth muscle, the relaxant effect of isopre‐
naline on MCh-induced contraction was gradually attenuated with increasing [Ca2+]i following
repeated exposure to isoprenaline with MCh for 10 min every 30 min [10, 135] (Figure 6B), and
this reduced responsiveness to isoprenaline was avoided by pre-exposure to cholera toxin or
the addition of verapamil with no change in [Ca2+]i [10] (Figure 6C). In contrast, after repeated
exposure to forskolin, db-cAMP and theophylline, the relaxant effect of these cAMP-related
agents was not diminished with no change in [Ca2+]i (homologous desensitization) [10, 135].
Furthermore, after exposure to PDGF for 15 min, the relaxant effect of isoprenaline against
MCh-induced contraction was markedly attenuated with increasing [Ca2+]i, and this reduced
responsiveness to isoprenaline was reversed by verapamil [139]. The relaxant effects of not
only β2-adrenoceptor agonists but also forskolin are markedly attenuated with elevated
[Ca2+]i after exposure to growth factors, such as TGFβ1 and PDGF (heterologous desensitiza‐
tion) (Figure 8). In contrast, the relaxant effects of db-cAMP and theophylline are not dimin‐
ished after exposure to TGFβ1 and PDGF. These results indicate that β2-adrenergic
desensitization occurs via dysfunction of the receptor/Gs/adenylyl cyclase processes in airway
smooth muscle and that the cAMP-independent pathway is involved in this phenomenon [3,
4. 7, 8]. These results indicate that the Ca2+ influx passing through VDC is involved in β2-
adrenergic desensitization and that VDC activity may be augmented by dysfunction of the
Gs/KCa channel stimulatory linkage (Figures 5, 8).
6.3.2. Ca2+ sensitization
In fura-2–loaded tissues of guinea pig tracheal smooth muscle, the inhibitory effect of isopre‐
naline against MCh-induced contraction following continuous exposure to Lyso-PC [140] was
markedly attenuated with no changes in [Ca2+]i (Figure 7A). This reduced responsiveness to
isoprenaline was reversed to the control response by application of Y-27632 in a concentration-
dependent manner (Figure 7B). In contrast, the relaxant effect of cAMP-related agents such as
forskolin, theophylline, and db-cAMP, was not diminished after exposure to Lyso-PC (ho‐
mologous desensitization). Similar to Lyso-PC, reduced responsiveness to isoprenaline was
observed with no changes in [Ca2+]i after the exposure of tracheal smooth muscle to tryptase
and SLIGKV [112] and S1P [141]. The relaxant effects of forskolin were not attenuated after
exposure to tryptase and SLIGKV; in contrast, the relaxant effects were markedly diminished
after exposure to S1P, indicating that the receptor/Gs/ adenylyl cyclase process is also involved
in the dysfunction of β2-adrenoceptors in airway smooth muscle. cAMP activity may still be
intact under this condition of excessive stimulation of β2-adrenoceptors. Furthermore, in the
presence of bisindolylmaleimide, a membrane-permeable inhibitor of PKC, reduced respon‐
siveness to isoprenaline is not prevented after exposure to an agonist [134, 135, 140]. These
observations indicate that after exposure to these lipid mediators and PAR 2 agonists, tolerance
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to β2-adrenoceptor agonists occurs due to Ca2+ sensitization via the RhoA/Rho-kinase proc‐
esses, not via PKC. This β2-adrenergic desensitization is caused by elevated sensitization to
intracellular Ca2+ based on Gs inactivation and Rho-kinase activation, although little is known
about the functional relationship between Gs and RhoA/Rho-kinase (Figures 5, 8).
6.3.3. Intrinsic efficacy
The potency of a β2-adrenoceptor agonist depends on its receptor affinity and intrinsic efficacy.
Intrinsic efficacy (intrinsic activity) refers to the ability of an agent to activate its receptors
without regard for their concentration. Some agonists completely activate receptors, but others
only partially activate them. The former are referred to as full agonists, and the latter are
(A) 
(B) 
Figure 7. The effects of Ca2+ sensitization mediated by RhoA/Rho-kinase on β-adrenergic desensitization in tracheal
smooth muscle. A: A typical example of simultaneously recorded isometric tension (upper trace) and F340/F380 ratio
(lower trace) induced by MCh (1 μM) with ISO (0.3 μM) inhibition before and after exposure to Lyso-PC (10 M) for 15
min. Pretreatment with Lyso-PC attenuates ISO-induced relaxation without elevating [Ca2+]i, indicating that Ca2+ sensi‐
tization is involved in β2-adrenergic desensitization. B: A typical example of the inhibitory effects of ISO (0.3 μM) on
MCh-induced contraction (1 μM) before and after exposure to Lyso-PC (10 μM) for 15 min in the absence (upper trace)
and presence (lower trace) of Y-27632 (10 μM) throughout the experiments. Y-27632 inhibits β2-adrenergic desensitiza‐
tion induced by Lyso-PC, indicating that Ca2+ sensitization via RhoA/Rho-kinase processes is involved in this phenom‐
enon. MCh: methacholine, ISO: isoprenaline, Lyso-PC: lysophosphatidylcholine. Cited from ref. [140].
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referred to as partial agonists. Moreover, partial agonists are subclassified as weak partial
agonists, which have lower efficacy, and strong partial agonists, which have higher efficacy
[144, 145]. Intrinsic efficacy was measured indirectly as a physiological response (changes in
smooth muscle relaxation determined by isometric tension recording in vitro) [145]. The ratio
of the intrinsic efficacy of any two β2-agonists is expressed as a fraction between 0 and 1 by
concentration-inhibition curves, taking that of adrenaline as 1. The order of efficacy (the
maximal percent relaxation against 10 μM MCh-induced contraction) was as follows: isopre‐
naline = adrenaline > indacaterol, formoterol, procaterol > salbutamol > salmeterol > tulobu‐
terol [97, 145] (Table 1); these efficacies are similar to the values measured by changing the
level of intracellular cAMP [144]. Isoprenaline behaves as a full agonist, and other agonists
behave as partial agonists. Isoprenaline caused β2-aderergic desensitization greater than that
of other agonists, indicating that excessive activation of a full agonist leads to reduced
responsiveness to β2-adrenoceptor agonists in airway smooth muscle [134, 135, 136, 142, 145].
In contrast, tulobuterol, which is the weakest partial agonist, caused a modest reduction in





























Figure 8. Role of Ca2+ dynamics and Ca2+ sensitization in the desensitization of β2-adrenoceptors in airway smooth
muscle. Phosphorylation of β2-adrenoceptors is essential for reduced responsiveness to their agonists. There are two
pathways in the mechanisms of β2-adrenergic desensitization: 1) cAMP-independent phosphorylation of their recep‐
tors via members of the GRK family such as βARK (homologous desensitization), and 2) cAMP-dependent phosphory‐
lation of their receptors via PKA (heterologous desensitization). Inactivation of Gs, which is linked to β2-adrenoceptors,
is involved in desensitization of the receptors mediated by Ca2+ dynamics and Ca2+ sensitization. Impairment of the
stimulatory linkage between Gs/PKA and KCa channels causes an increase in the membrane potential, leading to Ca2+
influx passing through VDC channels (Ca2+ dynamics: Ca2+-dependent mechanisms). On the other hand, impairment of
the inhibitory correlation between Gs/PKA and RhoA/Rho-kinase processes causes an increase in Rho-kinase activity,
leading to a reduced MP activity (Ca2+ sensitization: Ca2+-independent mechanisms). β2: β2-adreneceptors, AC: adenyl‐
yl cyclase, GRK: G protein-receptor kinase, βARK: β-adrenoceptor kinase, PKA: protein kinase A, MLCK: myosin light
chain kinase, MLC: myosin light chain, MP: myosin phosphatase, KCa: large-conductance Ca2+-activated K+ channels,
VDC: L-type voltage-dependent Ca2+ channels. Illustrated based on ref. [1, 2, 10, 112, 134, 135, 136, 138, 139, 140, 141,
142, 145, 146].
Muscle Cell and Tissue312
2-adrenoreptor




























Table 1. Intrinsic efficacy of β2-adrenoceptor agonists. Values of intrinsic efficacy of β2-adrenoceptor agonists were
measured as a physiologic response in airway smooth muscle. The values of intrinsic efficacy were expressed as the
maximum percent inhibition for each β2-adrenoceptor agonist against MCh-induced contraction (1 and 10 μM) in
guinea pig tracheal smooth muscle. MCh: methacholine. Cited from ref. [1, 97, 145].
6.4. Airway remodeling
Airway inflammatory reactions involving activated eosinophils act on the epithelium,
subepithelium, and smooth muscle layers and bring about characteristic structural changes in
the airways. Subepithelial fibrosis results from the deposition of collagen fibers and proteo‐
glycans under the basement membrane (thickening of the airway wall). This phenomenon is
known as airway remodeling, which is thought to be related to asthma severity. Airway
smooth muscle contributes to airway remodeling by mass formation via cell proliferation and
migration [147, 148]. Unlike normal cells, increased airway smooth muscle cell proliferation
in patients with asthma is not suppressed by glucocorticosteroids because of CCAAT/
enhancer-binding protein (C/EBP)-α deficiency in airway smooth muscle cells [149].
6.4.1. Cell proliferation
Factors facilitating the proliferation of airway smooth muscle cells are roughly divided into
the following two groups: 1) ligands (polypeptide growth factors) of tyrosine kinase receptors
(RTKs), such as epidermal growth factor (EGF) and PDGF, and 2) ligands (contractile agents)
of GPCRs, such as leukotriene D4, thromboxane A2 and endothelin. When ligands bind to
growth factor receptors, tyrosine kinase is first activated, followed by Ras and extracellular
regulated kinase (ERK)1/2, to transmit information to the nucleus [150]. Next, via cyclin D1
activation, DNA synthesis and cell proliferation occur [151]. In addition to this main pathway
for smooth muscle proliferation, cross-talk between RTKs and GPCRs is mediated by phos‐
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phatidylinositol 3-kinase (PI3K), p70S6 kinase, and glycogen synthase kinase-3 (GSK-3) [150,
152]. The involvement of the Rho family (RhoA, Rac and Cdc42) in the control mechanisms of
airway smooth muscle cell proliferation has not been sufficiently clarified. EGF- and PDGF-
induced cell proliferation is not suppressed by inactivation of RhoA/Rho-kinase signaling
[126]; in contrast, the activation of RhoA, not Rac or cdc42, causes the proliferation of human
bronchial smooth muscle cells that have been stimulated with serum. This proliferative
reaction is suppressed by Y-27632, C3 exoenzyme, and simvastatin, a HMG-CoA reductase
inhibitor, which attenuate proliferation via the geranylgeranylation of RhoA [153]. Another
factor, M2 muscarinic receptor, facilitates the proliferation of airway smooth muscle cells [154,
155]. A recent clinical trial has demonstrated that an antagonist of VDC channels inhibits
airway remodeling in patients with severe asthma [156]. Therefore, Ca2+ influx via VDC
channels is enhanced since KCa channel activity is attenuated by Gi when MCh is applied to
airway smooth muscle [7, 8]. These results indicate that both Ca2+ dynamics and Ca2+ sensiti‐
zation contribute to the proliferation of airway smooth muscle cells (Figure 5).
6.4.2. Cell migration
Cell migration is a characteristic function of inflammatory cells, fibroblasts and smooth muscle
cells, and it plays an important role in various pathophysiological environments, such as
inflammatory cell infiltration and airway smooth muscle hyperplasia [157]. Migration of
airway smooth muscle cells is enhanced by the extracellular matrix [158]. Cell migration occurs
due to contraction involving actin, myosin reactions and actin reorganization. Since RhoA/
Rho-kinase signaling is the most important factor controlling the cytoskeleton of airway
smooth muscle cells and other cells [159], this pathway may control the migration of airway
smooth muscle cells via changes in the cytoskeleton. Hence, RhoA/Rho-kinase may be
involved in airway remodeling mediated not only by cell proliferation but also by cell
migration. Urokinase, PDGF, leukotriene and lysophosphatidic acid facilitate the migration of
human airway smooth muscle cells [160, 161, 162, 163]. Moreover, heat shock protein, PI3K,
p38 mitogen-activated protein kinase, prostaglandin D2, and IL-13 facilitate airway smooth
muscle migration [160, 164, 165]. Y-27632 significantly suppresses the increased migration of
airway smooth muscle cells, due to PDGF or leukotriene stimulation [161, 162], indicating that
RhoA/Rho-kinase signaling (Ca2+ sensitization) plays an important role in controlling cell
migration (Figure 5). On the other hand, Ca2+ dynamics regulate the migration of airway
smooth muscle cells and inflammatory cells. Ca2+ influx via SOC channels contributes to PDGF-
induced cell migration of airway smooth muscle [166], and increasing [Ca2+]i via other
mechanisms also causes substance P–induced cell migration of airway smooth muscle [167]
(Figure 5). Since IL-13 enhances Ca2+ oscillation in airway smooth muscle cells, cell migration
induced by IL-13 may be regulated by Ca2+ dynamics [168].
6.4.3. Interaction between airway smooth muscle and inflammatory cells
As described earlier, contractility of airway smooth muscle is altered by tryptase and S1P,
which are released from mast cells, and Lyso-PC, which is synthesized in the membrane of
various inflammatory cells [108, 112, 140, 141]. Ca2+ sensitization by RhoA/Rho-kinase
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processes contributes to this phenomenon. When sensitized mice are subjected to allergen
challenges, eosinophil infiltration is markedly increased in the airways. In allergen-challenged
mice, pretreatment with Rho-kinase inhibitors such as Y-27632 or fasudil hydrochloride
(HA-1077) markedly suppressed an increase in eosinophil recruitment in the airway in a dose-
dependent manner [128]. The actions of Lyso-PC are mediated by RhoA/Rho-kinase, leading
to β2-aderenergic desensitization [140], and administration of Lyso-PC to guinea pigs enhances
eosinophil recruitment and resistance in the airways [169]. The effects of S1P are also mediated
by RhoA/Rho-kinase processes, leading to airway hyperresponsiveness [108] and remodeling
[170]. S1P increased mRNA and protein expression of vascular cell adhesion molecule
(VCAM)-1 when S1P is applied to pulmonary endothelial cells, leading to eosinophil infiltra‐
tion to the airways, and this upregulation of VCAM-1 is attenuated by C3 exoenzyme and
Y-27632 [171]. Y-27632 reduces not only the number of eosinophils but also macrophages and
neutrophils in an animal model of allergic asthma [172]. Ca2+ sensitization via RhoA/Rho-
kinase processes contributes to recruitment of inflammatory cells to the airways.
Therefore, Ca2+ sensitization by RhoA/Rho-kinase processes [1, 173, 174, 175] and Ca2+
dynamics by ion channels including VDC and SOC [6, 11, 12, 176] may be a therapeutic target
for obstructive pulmonary diseases including asthma.
7. Conclusions
Ca2+ signaling, which is due to Ca2+ dynamics and Ca2+ sensitization, contributes to alterations
of contractility that lead to airway disorders (airflow limitation, airway hyperresponsiveness,
and β2-adrenergic desensitization), which are characteristic features of asthma and COPD.
Ca2+ dynamics and Ca2+ sensitization also facilitate the proliferation and migration of airway
smooth muscle via changing to proliferative phenotype. A recent report has indicated that
bitter taste receptor stimulation causes relaxation of airway smooth muscle via activation of
KCa channels [177]. Hence, Ca2+ dynamics due to G proteins/KCa/VDC channels and Ca2+
sensitization due to RhoA/Rho-kinase processes may be therapeutic targets for asthma and
COPD, and research in these areas may provide novel strategies in the development of
bronchodilators for these diseases.
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